It is important to investigate the possible roles of PCAF and GCN5 activities in regulating TGF-β and TLR7 signalling pathways in severe COVID-19 for novel treatments to ameliorate the severity and prevent COVID-19 fatalities. The gene discussed is KAT2B; the disease is COVID-19.